
Baymax Research, Inc.
Free shipping on orders over $99 · 30-day returns
MiMo(TM) Negative Pressure Wound Therapy System is an FDA 510(k)-cleared medical device (K181929) manufactured by Baymax Research, Inc.. This device is classified under the General, Plastic Surgery specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on March 26, 2019. Regulation: 8.